These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 6044451)

  • 61. Genetic effects of drug interaction in tuberculosis patients and their fate.
    Jaju M; Jaju M; Ahuja YR
    Teratog Carcinog Mutagen; 1984; 4(3):261-72. PubMed ID: 6205465
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Isoniazid (INH)-induced eosinophilic exudative pleural effusion and lupus erythematosus. A clinical reminder of drug side effects.
    Khattri S; Kushawaha A; Dahal K; Lee M; Mobarakai N
    Bull NYU Hosp Jt Dis; 2011; 69(2):181-4. PubMed ID: 22035399
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [On the problem of chronic liver damage following drug therapy of tuberculosis].
    Petera V; Klapálek D; Paichl P; Pecený A
    Dtsch Z Verdau Stoffwechselkr; 1965 Oct; 25(4):250-2. PubMed ID: 5888913
    [No Abstract]   [Full Text] [Related]  

  • 64. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 65. [Lung resection in patients with tuberculosis, demonstrating symptoms of antitubercular drug hypersensitivity].
    Akmatov TA
    Sov Zdravookhr Kirg; 1972; 6():43-6. PubMed ID: 4666880
    [No Abstract]   [Full Text] [Related]  

  • 66. The need for new antituberculous drugs.
    Dahlström G
    Scand J Respir Dis Suppl; 1969; 69():11-3. PubMed ID: 4906370
    [No Abstract]   [Full Text] [Related]  

  • 67. [Fatal Lyell's syndrome in a tuberculous patient during treatment].
    Faye I; Marchand JP; Warion B; Renault-Steens CJ; N'Diaye B
    Bull Soc Med Afr Noire Lang Fr; 1974; 19(2):185-7. PubMed ID: 4466585
    [No Abstract]   [Full Text] [Related]  

  • 68. Serum transaminase levels in pulmonary tuberculosis. Effect of triple treatment with 4-4 1-di-isoamyloxythiocarbanilide or PAS in combination with streptomycin and isoniazid.
    Ockerman PA; Ryde C
    Scand J Respir Dis; 1968; 49(1):35-41. PubMed ID: 5187250
    [No Abstract]   [Full Text] [Related]  

  • 69. Fungal infecton of central nervous system supervening during routine chemotherapy for pulmonary tuberculosis.
    Spens N; Tattersall WH
    Br Med J; 1965 Oct; 2(5466):862. PubMed ID: 5827803
    [No Abstract]   [Full Text] [Related]  

  • 70. [Current established major antibiotic therapy of pulmonary tuberculosis].
    Aksüğür H
    Turk Tip Cemiy Mecm; 1967 Aug; 33(8):465-74. PubMed ID: 5600601
    [No Abstract]   [Full Text] [Related]  

  • 71. Serum transaminase levels during treatment with isoniazid, streptomycin and PAS.
    Smith JM; Springett VH
    Tubercle; 1966 Sep; 47(3):245-9. PubMed ID: 5971411
    [No Abstract]   [Full Text] [Related]  

  • 72. [Our region's possibilities in the ambulatory treatment of pulmonary tuberculosis with the biweekly administration of a perfused triple combination of isoniazid, streptomycin and PAS].
    Burghard G; Petitjean R; Scherrer B; Schranz J
    Rev Tuberc Pneumol (Paris); 1970; 34(5):662-3. PubMed ID: 5496786
    [No Abstract]   [Full Text] [Related]  

  • 73. [Interaction of streptomycin, Tubazid and PAS according to myorelaxant and lethal effects].
    Soloviev NV; Berezhinskaia VV
    Antibiotiki; 1973 Mar; 18(3):249-52. PubMed ID: 4764220
    [No Abstract]   [Full Text] [Related]  

  • 74. [OUR EXPERIENCE WITH THE TREATMENT OF PULMONARY TUBERCULOSIS RESISTANT TO CLASSICAL TUBERCULOSTATIC DRUGS].
    KOVACEVIC M; MILUTINOVIC R; KONJOVIC M; ZIGIC M
    Tuberkuloza; 1963; 15():250-3. PubMed ID: 14067279
    [No Abstract]   [Full Text] [Related]  

  • 75. [Some factors contributing to the development of side effects in antibacterial treatment of patients with pulmonary tuberculosis].
    Sergeev IS; Pervova TN; Ignatova AV
    Probl Tuberk; 1967; 45(9):35-40. PubMed ID: 5606476
    [No Abstract]   [Full Text] [Related]  

  • 76. [Methemoglobinemia and hemolytic anemia caused by para-aminosalicylic acid (PAS) infusion therapy].
    Mastella G; Orlandi P; Garofalo E; Lorenzini E
    Fracastoro; 1966; 59(6):702-16. PubMed ID: 5301822
    [No Abstract]   [Full Text] [Related]  

  • 77. [Cases of leukopenia caused by PAS allergy].
    Fukui S
    Iryo; 1966 Mar; 20(3):282-5. PubMed ID: 5964835
    [No Abstract]   [Full Text] [Related]  

  • 78. [Adverse reactions to short-course anti-tuberculous therapy (author's transl)].
    Carrasco E
    Rev Med Chil; 1981 Jun; 109(6):566-72. PubMed ID: 7330536
    [No Abstract]   [Full Text] [Related]  

  • 79. Management of tuberculosis in elderly persons.
    Nagami P; Yoshikawa TT
    Compr Ther; 1984 Jul; 10(7):57-62. PubMed ID: 6540155
    [No Abstract]   [Full Text] [Related]  

  • 80. [Mechanism of action and effectiveness of intravenous administration of tubazid, streptomycin and PAS in the therapy of pulmonary tuberculosis].
    Pilipchuk NS; Ivaniuota OM; Kovalenko NN
    Probl Tuberk; 1970; 48(1):26-30. PubMed ID: 5425441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.